Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CILTACABTAGENE AUTOLEUCEL Cause Product label issue? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Product label issue have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 0.3% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.

13
Reports of Product label issue with CILTACABTAGENE AUTOLEUCEL
0.3%
of all CILTACABTAGENE AUTOLEUCEL reports
1
Deaths
0
Hospitalizations

How Dangerous Is Product label issue From CILTACABTAGENE AUTOLEUCEL?

Of the 13 reports, 1 (7.7%) resulted in death.

Is Product label issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?

Cytokine release syndrome (570) Pyrexia (242) Immune effector cell-associated neurotoxicity syndrome (232) Parkinsonism (209) Hospitalisation (193) Adverse event (143) Neurotoxicity (140) Death (130) Malaise (126) Fatigue (123)

What Other Drugs Cause Product label issue?

RIVAROXABAN (379) ACETAMINOPHEN (276) GUSELKUMAB (177) USTEKINUMAB (164) DIMETHICONE\LOPERAMIDE (154) CETIRIZINE (138) IBUPROFEN (99) GOLIMUMAB (76) POLYETHYLENE GLYCOL 3350 (76) FENTANYL (72)

Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Product label issue Risk?

CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE CILTACABTAGENE AUTOLEUCEL vs CIMZIA CILTACABTAGENE AUTOLEUCEL vs CINACALCET CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE CILTACABTAGENE AUTOLEUCEL vs CINRYZE

Related Pages

CILTACABTAGENE AUTOLEUCEL Full Profile All Product label issue Reports All Drugs Causing Product label issue CILTACABTAGENE AUTOLEUCEL Demographics